The Senate Health, Education, Labor, and Pensions Committee is scheduled to vote Thursday morning on whether to advance Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention, and the agency she would inherit is managing more simultaneous outbreaks than at any point in recent years.
The executive session is set for 9:45 a.m. Eastern in 430 Dirksen Senate Office Building, according to the committee's published notice. Schwartz's nomination appears on the agenda alongside Sean Kaufman's nomination to be assistant secretary for preparedness and response.
A vote scheduled for July 23 was postponed after Sen. Lisa Murkowski was absent for a family emergency, leaving Republicans short of the members needed. The committee's next opportunity is Thursday.
For readers, the practical stake is not the political scoreboard. It is that the federal agency that publishes weekly outbreak counts, issues vaccination guidance, and supports state health departments has operated without a permanent director for most of the past year while case numbers climbed.
The Workload Waiting on Day One
Measles is the largest item. The United States confirmed 2,318 cases in 2026 as of July 23, surpassing the 2,289 recorded in all of 2025 and making this the worst year since 1991, according to CDC surveillance data. Cases have been reported across 45 jurisdictions, and 93 percent are outbreak-associated. About 7 percent of patients have been hospitalized. No deaths have been reported this year.
A separate parasitic outbreak is running in parallel. CDC and FDA are investigating a multistate Cyclospora outbreak linked to iceberg lettuce from Taylor Farms de Mexico, with 1,947 confirmed cases across nine states and at least 98 hospitalizations. Beyond that cluster, CDC has recorded 1,645 domestically acquired cyclosporiasis cases across 34 states since May 1, compared with 249 during the same window in 2025.
West Nile virus season is entering its historical peak, with 91 confirmed human cases across 20 states as of July 21. New World screwworm has been confirmed in 42 animals in Texas and New Mexico.
The leadership bench is thin. The CDC director post is one of several senior vacancies at the Department of Health and Human Services, alongside the Surgeon General and the Commissioner of the Food and Drug Administration. Dr. Jay Bhattacharya, who directs the National Institutes of Health, has served as acting CDC director since February. Schwartz would be the fourth person named or nominated to run the agency since last summer.
Where the Two Key Senators Stand
Committee chair Sen. Bill Cassidy announced his support after the CDC altered language on its website regarding vaccines and autism, a change he characterized as a good faith action by the administration. In a statement reported by CNN, Cassidy said that after speaking with Schwartz again and reviewing her hearing transcript, he is confident "she knows what she is doing and will stand against those who don't."
Ranking member Sen. Bernie Sanders said he would vote no. "I will be voting against Dr. Schwartz," Sanders said in remarks reported by UPI, adding that he respected her career but was not persuaded she could resist pressure from Health Secretary Robert F. Kennedy Jr.
Schwartz, 54, is a physician and retired rear admiral in the U.S. Public Health Service who served as deputy surgeon general. She earned her medical degree at Brown University and was nominated in April. If confirmed, she would become the 22nd CDC director.
At her July 15 hearing, reported by NPR, she pledged what she called radical transparency and said she would never betray the science. She also told senators, "I want to be the CDC director for all Americans," including those with concerns about vaccines. She accepted that overwhelming evidence shows vaccines do not cause autism but did not commit to removing the CDC webpage on the subject.
Financial disclosures filed last month indicate Schwartz would leave her position at UnitedHealth Group, where she earns roughly $850,000 in salary and bonus, and cash out her stock options if confirmed.
Dr. Debra Houry, the CDC's former chief medical officer who resigned after the removal of the previous director, told TIME that Schwartz "has the right qualifications" while noting that senators appeared frustrated by her answers on political interference.
What a Confirmed Director Would and Would Not Change
A CDC director does not personally stop an outbreak, and readers should not expect Thursday's vote to alter case counts.
What the position does affect is more mundane and more consequential over months: whether weekly surveillance publishing stays on schedule, whether state and local health departments get technical assistance and epidemiologists deployed to outbreak sites, whether vaccine guidance is issued on a predictable timeline, and whether the agency retains staff. CDC has lost substantial workforce capacity since the start of the administration, and reduced capacity shows up locally as slower case investigation and delayed data.
For a household, that translates into practical questions. Whether a county health department has enough staff to trace measles exposures before a school year begins. Whether a foodborne outbreak source is identified in weeks rather than months. Whether a parent can find current, clear guidance on when to vaccinate an infant in an outbreak county.
None of that depends on a single vote. All of it depends on whether the agency has stable leadership over the next year.
What Happens Next
If the committee advances Schwartz, the nomination moves to the full Senate floor. The previous CDC director cleared the committee 12 to 11, and the floor 51 to 47, and a similarly narrow path is plausible here, though the timing of a floor vote has not been announced.
The committee had not scheduled a vote on Kaufman's nomination as of the July 23 session, with a committee spokesperson citing ongoing conversations with the administration; his nomination appears on Thursday's agenda. The session will be streamed publicly.
Separately, the Pan American Health Organization is expected to review U.S. measles elimination status in November. The United States has held that status since 2000, and sustained transmission this year has put it in question.
The newest confirmed fact is a scheduled committee vote on Thursday, July 30. The people most affected are families in communities with active measles, Cyclospora, or West Nile transmission who depend on state health departments that in turn depend on federal support. The most reasonable action for readers is to follow local health department guidance rather than waiting on federal appointments. The central uncertainty is whether the committee has the votes, and whether a confirmed director can stabilize an agency in its fourth leadership transition in a year.
Developing Story Timeline
July 27, 2026: The Senate HELP Committee publishes an updated notice scheduling an executive session for July 30, including the CDC and ASPR nominations.
July 23, 2026: The committee postpones the scheduled vote after Sen. Lisa Murkowski's absence. Chairman Cassidy announces support for Schwartz; Sen. Sanders announces opposition.
July 15, 2026: Schwartz testifies at her confirmation hearing alongside ASPR nominee Sean Kaufman.
April 2026: President Trump nominates Schwartz to lead the CDC.
Frequently Asked Questions
When is the Senate committee vote? Thursday, July 30, 2026, at 9:45 a.m. Eastern in 430 Dirksen Senate Office Building. The session will be streamed publicly.
Who is Erica Schwartz? A 54-year-old physician and retired rear admiral in the U.S. Public Health Service who served as deputy surgeon general. She holds a medical degree from Brown University and was nominated in April. She currently works at UnitedHealth Group and has said she would leave that role if confirmed.
Why was the earlier vote postponed? Sen. Lisa Murkowski was absent for a family emergency, leaving committee Republicans short of the members needed for the vote. The nomination was carried over to the next executive session.
Does the CDC currently have a director? Not a permanent one. Dr. Jay Bhattacharya, who directs the National Institutes of Health, has served as acting CDC director since February.
How bad is the measles situation the nominee would inherit? The United States confirmed 2,318 cases as of July 23, the highest annual total since 1991, across 45 jurisdictions, with 93 percent linked to outbreaks and about 7 percent of patients hospitalized.
Does this vote affect my family's health care directly? Not immediately. It affects whether the agency that supports state and local health departments has stable leadership, which over months influences outbreak investigation speed, data publishing, and guidance timelines.
What other senior health positions are vacant? Surgeon General and Commissioner of the Food and Drug Administration are both unfilled, as is Assistant Secretary for preparedness and response, which is also on Thursday's committee agenda.
